SecuritySKIS / Peak Resorts, Inc. (70469L100)
IndustryHotels and Motels
Institutional Owners36
Institutional Shares6,404,236 - 45.80%
Common Stock Shares Outstanding13,982,400 shares (as of 2018-01-31)
Institutional Value$ 31,084,000 USD

Institutional Stock Ownership and Shareholders()

SKIS / Peak Resorts, Inc. Institutional Ownership

Peak Resorts, Inc. (NASDAQ:SKIS) has 36 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 6,404,236 shares. Largest shareholders include Summer Road Llc, American Financial Group Inc, Rutabaga Capital Management Llc/ma, Vanguard Group Inc, Bridgeway Capital Management Inc, Sterneck Capital Management, LLC, Russell Investments Group, Ltd., Falcon Point Capital, Llc, Renaissance Technologies LLC, and Bard Associates Inc.
Peak Resorts, Inc. (NASDAQ:SKIS) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

Embed this chart! (it updates automatically)
<a href="https://fintel.io/so/us/skis"><img src="https://images.fintel.io/us-skis-so.png" alt="SKIS / Peak Resorts, Inc. Institutional Ownership"><a>

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-05-15 13F-HR BANK OF AMERICA CORP /DE/ 1,118 1,000 -10.55 6 5 -16.67
2018-04-26 13F-HR ESSEX INVESTMENT MANAGEMENT CO LLC 74,872 67,791 -9.46 404 329 -18.56
2018-05-18 13F-HR/A ROYAL BANK OF CANADA 2,509 2,500 -0.36 13 12 -7.69
2018-05-09 13F-HR IFP Advisors, Inc 600 3
2018-05-14 13F-HR Perigon Wealth Management, LLC 141 141 0.00 1 1 0.00
2018-05-11 13F-HR AMERICAN FINANCIAL GROUP INC 1,245,986 1,245,986 0.00 6,728 6,043 -10.18
2018-05-14 13F-HR WHITE PINE CAPITAL LLC 24,000 116
2018-04-26 13F-HR SIMPLEX TRADING, LLC 1,891 0 -100.00 10 0 -100.00
2018-05-15 13F-HR DEUTSCHE BANK AG\ 51,997 38,321 -26.30 280 185 -33.93
2018-05-15 13F-HR Bank of New York Mellon Corp 21,189 19,900 -6.08 114 97 -14.91
2018-05-11 13F-HR STIFEL FINANCIAL CORP 23,911 21,411 -10.46 130 104 -20.00
2018-05-09 13F-HR NORTHERN TRUST CORP 22,582 24,405 8.07 122 118 -3.28
2018-04-26 13F-HR FALCON POINT CAPITAL, LLC 125,000 125,000 0.00 675 606 -10.22
2018-04-27 13F-HR ENTERPRISE FINANCIAL SERVICES CORP 1,000 1,000 0.00 5 5 0.00
2018-05-14 13F-HR MORGAN STANLEY 9,774 990 -89.87 53 5 -90.57
2017-10-26 13F-HR Acrospire Investment Management LLC 12,773 0 -100.00 52 0 -100.00
2018-05-14 13F-HR CARDINAL CAPITAL MANAGEMENT LLC /CT 40,270 0 -100.00 217 0 -100.00
2018-05-11 13F-HR PINNACLE ASSOCIATES LTD 100,469 99,869 -0.60 543 484 -10.87
2018-05-10 13F-HR Spark Investment Management LLC 33,600 0 -100.00 181 0 -100.00
2018-05-14 13F-HR Renaissance Technologies LLC 139,700 116,821 -16.38 754 567 -24.80
2017-11-09 13F-HR TFS CAPITAL LLC 30,847 0 -100.00 126 0 -100.00
2018-05-15 13F-HR Brandywine Global Investment Management, LLC 7,289 5,908 -18.95 40 29 -27.50
2018-05-15 13F-HR BRIDGEWAY CAPITAL MANAGEMENT INC 319,400 319,400 0.00 1,725 1,549 -10.20
2018-05-08 13F-HR SUMMER ROAD LLC 1,926,500 1,926,500 0.00 10,403 9,344 -10.18
2018-05-15 13F-HR UBS Group AG 17,541 20,167 14.97 94 97 3.19
2018-05-09 13F-HR BlackRock Inc. 37,256 36,614 -1.72 201 177 -11.94
2018-05-16 13F-HR/A GROUP ONE TRADING, L.P. 300 0 -100.00 2 0 -100.00
2018-05-11 13F-HR GSA CAPITAL PARTNERS LLP 62,228 58,928 -5.30 336 286 -14.88
2018-05-11 13F-HR Russell Investments Group, Ltd. 63,949 160,190 150.50 333 776 133.03
2018-05-14 13F-HR BARD ASSOCIATES INC 114,675 106,125 -7.46 619 515 -16.80
2018-05-14 13F-HR Resources Investment Advisors, Inc. 6,000 6,000 0.00 32 29 -9.37
2017-02-10 13F-HR BlackRock Investment Management, LLC 2,080 2,080 0.00 11 12 9.09
2018-04-12 13F-HR Sterneck Capital Management, LLC 241,975 227,895 -5.82 1,307 1,105 -15.46
2018-05-14 13F-HR BOKF, NA 23,650 23,650 0.00 128 115 -10.16
2018-05-11 13F-HR DIMENSIONAL FUND ADVISORS LP 68,299 72,946 6.80 369 354 -4.07
2018-05-15 13F-HR GEODE CAPITAL MANAGEMENT, LLC 27,108 27,108 0.00 146 131 -10.27
2017-02-10 13F-HR BlackRock Fund Advisors 29,796 30,612 2.74 153 170 11.11
2018-05-02 13F-HR WELLS FARGO & COMPANY/MN 28,940 40,640 40.43 157 198 26.11
2018-05-15 13F-HR VANGUARD GROUP INC 402,953 432,148 7.25 2,176 2,096 -3.68
2018-04-26 13F-HR RUTABAGA CAPITAL MANAGEMENT LLC/MA 938,451 1,046,176 11.48 5,068 5,074 0.12
2018-04-20 13F-HR Seacrest Wealth Management, Llc 434 734 69.12 2 4 100.00
2018-05-10 13F-HR Municipal Employees' Retirement System of Michigan 70,680 70,680 0.00 382 343 -10.21

Related Articles

CASC: Cascadian Therapeutics Analysis and Research Report

2018-06-22 - Asif

Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...

BAC: Bank of America Corp. Analysis and Research Report

2018-06-22 - Asif

Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

Related News Stories

10 Dividend Stocks to Buy in May | InvestorPlace

2018-05-03 investorplace
For the past few years, it has been slim pickings for dividend investors. High yields have been hard to find, and what opportunities did appear to exist, such as in the energy sector, often led to sizable losses that more than erased the seemingly attractive dividend yields. (154-0)

BRIEF-Permit Applications Approved For Hunter Mountain Trail Expansion Project

2018-04-05 reuters
* PEAK RESORTS INC - HUNTER MOUNTAIN SECURED ALL REQUIRED PERMITS WHICH WILL ALLOW IT TO MOVE FORWARD WITH TERRAIN EXPANSION PROJECT Source text for Eikon: Further company coverage: (1-0)

CUSIP: 70469L100